![BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1756-8722-4-6/MediaObjects/13045_2010_Article_140_Fig3_HTML.jpg)
BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance | Journal of Hematology & Oncology | Full Text
![The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ... The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ...](https://www.astctjournal.org/cms/attachment/4b4ceb2f-a5fa-4bb5-b3d6-9565f0ca7e4c/gr1_lrg.jpg)
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ...
![Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2017.36/MediaObjects/41375_2017_Article_BFleu201736_Fig1_HTML.jpg)
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
![Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram](https://www.researchgate.net/publication/328580053/figure/fig1/AS:962678705098752@1606531897003/Schematic-representation-of-BCR-and-ABL1-gene-structures-and-essential-protein-domains-of.png)
Schematic representation of BCR and ABL1 gene structures and essential... | Download Scientific Diagram
![Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia](https://www.frontiersin.org/files/Articles/81229/fonc-04-00054-HTML/image_m/fonc-04-00054-g002.jpg)
Frontiers | Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug | Journal of Medicinal Chemistry
![Versiti - Strategies to Target BCR-ABL1 Compound Mutants in CML and Ph+ALL | Michael Deininger Laboratory | Versiti Blood Research Institute Versiti - Strategies to Target BCR-ABL1 Compound Mutants in CML and Ph+ALL | Michael Deininger Laboratory | Versiti Blood Research Institute](https://media.versiti.org/versiti/versiti/media/page/blood-research-institute/investigator-labs/deininger/strategies-bcrabl1-card-445x280-2.jpg)
Versiti - Strategies to Target BCR-ABL1 Compound Mutants in CML and Ph+ALL | Michael Deininger Laboratory | Versiti Blood Research Institute
![Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/76e1ca46-30ec-49c1-b325-a7c53fedc91f/fx1_lrg.jpg)